Lv21
180 积分 2026-07-19 加入
When Causal is Not Enough
13天前
已完结
A modular framework for antibody-drug conjugate biomarkers
1个月前
已完结
Therapeutic targeting of RAS-mediated resistance in oncogene-driven lung cancer
2个月前
已完结
The B7-H3 (CD276) pathway: emerging biology and clinical therapeutics
3个月前
已完结
Evaluation of occult liver metastases in pancreatic adenocarcinoma by diffusion-weighted related magnetic resonance imaging
3个月前
已完结
The next generation of antibody–drug conjugates
3个月前
已完结
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy
3个月前
已完结
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer
3个月前
已完结
Targeting cyclin-dependent kinases in cancer: emerging therapeutics and clinical strategies
3个月前
已完结
皖公网安备34019202002308
